UNSPSC 51182014: Dutasteride

This classification denotes a 5 alpha-reductase inhibitor and anti-androgen with the molecular formula C27H30F6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O0J6XJN02I, chemically known as alpha,alpha,alpha,alpha,alpha,alpha-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2,5-xylidide but generally known as dutasteride, which bears US NIH Compound Identifier 152945. European Medicines Agency schedules Dutasteride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06430MIG.

UNSPSC 51182014 Dutasteride is a Commodity code for a specific pharmaceutical product — a 5-alpha reductase inhibitor used primarily in the treatment of benign prostatic hyperplasia. The recent state and local opportunities posted under this code show no meaningful procurement activity aligned with the code's nominal scope. The three most recent opportunities tagged to the code are a District Attorney's Office Dog procurement by Washington County, Oregon; athletic training services for Tucson Fire and Tucson Police by the City of Tucson; and medical aid supplies (antiseptic sprays, hydrogen peroxide, aspirin, bandages, first aid kits, emergency blankets) for the City of Tampa Fire Rescue Department. None of these solicitations involve dutasteride or any pharmaceutical procurement. The mismatch between the code and the actual work being procured indicates either miscategorization at the time of posting or a data-quality issue in the source system.

Given the absence of relevant recent state and local procurement activity under UNSPSC 51182014, the code presents minimal opportunity signal for business development purposes at this time. No issuing bodies are actively soliciting dutasteride, and no geographic concentration of pharmaceutical procurement under this code is evident. Firms seeking to pursue pharmaceutical supply contracts with state and local health departments, corrections systems, or public-safety agencies should monitor related UNSPSC family codes for pharmaceutical products and medical supplies rather than rely on recent activity in this Commodity code.